BLFS vs BFLY vs NVCR vs SONO

For growth investors, Butterfly Network, Inc.

(BFLY) is the stronger pick with 19. 0% revenue growth year-over-year, versus -4. 9% for Sonos, Inc. (SONO). Analysts rate BioLife Solutions, Inc. (BLFS) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, BioLife Solutions, Inc.

(BLFS) delivered a total return of -27. 0%, compared to -91. 3% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: BLFS returned +1221% versus BFLY's -57. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), BioLife Solutions, Inc.

(BLFS) is the lower-risk stock at 1. 67β versus Butterfly Network, Inc. 's 3. 28β — meaning BFLY is approximately 96% more volatile than BLFS relative to the S&P 500. On balance sheet safety, BioLife Solutions, Inc. (BLFS) carries a lower debt/equity ratio of 5% versus 85% for NovoCure Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Butterfly Network, Inc.

(BFLY) is pulling ahead at 19. 0% versus -4. 9% for Sonos, Inc. (SONO). On earnings-per-share growth, the picture is similar: BioLife Solutions, Inc. grew EPS 43. 2% year-over-year, compared to -64. 5% for Sonos, Inc.. Over a 3-year CAGR, BFLY leads at 10. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sonos, Inc.

(SONO) is the more profitable company, earning -4. 2% net margin versus -79. 0% for Butterfly Network, Inc. — meaning it keeps -4. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SONO leads at -3. 5% versus -88. 5% for BFLY. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Sonos, Inc.

(SONO) trades at 47. 3x forward P/E versus 156. 4x for BioLife Solutions, Inc. — 109. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, BioLife Solutions, Inc.

(BLFS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1221% 10Y return). Butterfly Network, Inc. (BFLY) carries a higher beta of 3. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BLFS: +1221%, BFLY: -57. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BLFS (Healthcare) and BFLY (Healthcare) and NVCR (Healthcare) and SONO (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BLFS is a small-cap high-growth stock; BFLY is a small-cap high-growth stock; NVCR is a small-cap quality compounder stock; SONO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.